Navigation Links
Cardiva Medical, Inc. to Present at the 'Investment In Innovation (In3) Medical Device Summit' on June 18, 2008 in San Francisco, CA; Announces the Completion of Its Latest Phase in Its US Sales Force Expansion
Date:6/16/2008

va Medical, Inc. is a privately held medical company focused on developing and commercializing devices which close the vascular access site with unsurpassed safety and ease-of-use. Cardiva's first product, the Boomerang Wire System, was approved in EU countries and in the US in 2004. Cardiva's second-generation product, the Boomerang Catalyst System, was approved in March 2007 and launched in July 2007. The enhanced Boomerang Catalyst, trade named as "Boomerang Catalyst II System" received 510(K) clearance in September 2007 and launched in January 2008. Cardiva was selected by Frost & Sullivan as the recipient of the 2006 Frost & Sullivan Award for Entrepreneurial Company in the U.S. angioplasty and vascular closure devices market. For additional information about Cardiva Medical, Inc. see our website at http://www.cardivamedical.com.

Cardiva, Boomerang and Boomerang Catalyst System are trademarks/registered trademarks of Cardiva Medical, Inc.

Media Contact:

Glenn Foy, President

Cardiva Medical, Inc.

Phone: 650.964.8900, x 215

Fax: 650.964.8911

glenn_foy@cardivamedical.com


'/>"/>
SOURCE Cardiva Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM)
2. Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM)
3. Cardiva Medical, Inc. Appoints Two New Officers: Malcolm Farnsworth as Vice President of Finance and Chief Financial Officer and Tara Zerby as Vice President of Business Development and Marketing
4. Cardiva Medical, Inc. to Present Highlights of the Boomerang Catalyst(TM) II System at the Investment in Innovation (In3) West Conference on February 29, 2008 in Las Vegas, NV
5. Cardiva Medical, Inc. Completes $15.5 Million Private Equity Financing
6. Medical, technological advances prompt updating of nuclear medicine technologists scope of practice
7. Thermage, Inc. Announces Distribution Agreement With Eclipse Medical, Ltd.
8. Medical, Behavioral Woes Can Drive Dogs to Bite
9. ReBuilder Medical Technologies, Inc. Announces UK Demand for Safe Molluscum Contagiosum Treatment Leads to Distribution Agreement with UFFE Medical, LTD. Expected 10% Sales Increase.
10. Sedgwick CMS and UnitedHealth Group to Develop Integrated Disability, Medical, Workers Compensation and Leave Administration Services for Employers
11. Emmaus Medical, Inc. Enters Into Sub-License Agreement for Treatment of Short Bowel Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2008)... New names and fresh websit... UME/GME administration software , ... one45 Software, a leading provider of healthcare ... of Cytiva Software Inc. (CRX:TSX.V), announced to...hcare education administration products., , ,Compl...
(Date:8/20/2008)... NEWTON, Mass., Aug. 20 /PRNewswire/ -- Questex M...o-business media company and owner of,American Spa... and the,International Beauty Shows, the Internati...) and the SPATEC appointment events today announce...stry portals SpaTrade (, http://www.SpaTrade.com ...
(Date:8/20/2008)... Survey Report Is Available at http://ww...Newswire/ -- A new survey released today,documents...re leveraging,health information technology (HIT) ...The survey results highlight the need for many HIT...dization and,interoperability to optimize clinical...
(Date:8/20/2008)...use postponed reproductive onset in teen, adult fe...EDNESDAY, Aug. 20 (HealthDay News) -- Alcoholism i...ccording to a study that compared women,s and men,... age when they had their first child. , The re...ian twins born between 1893-1964 (3,634 female and...
Breaking Medicine News(10 mins):Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 2Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 3Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 4Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 2Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 3Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 2Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 3Health News:Women's Alcohol Use Tied to Delayed Childbearing 2
...dard for the prevention and treatment of heart att...icans living with diabetes, the standard dose of a...st future heart attacks. Researchers have recently...n diabetics with coronary artery disease (CAD) tha...
...en with a recent diagnosis of cancer in one breast...// This study was conducted by the Chapel Hill r...international research team found that MRI, or mag...ed cancer in the opposite breast in 30 of 969 wome...
...in Texas in the US almost died of a choking game. ... games.// Levi was found suspended on a rope he h...s neck onto the rope. He wanted to achieve a surgi...t replenished just before the point of unconscious...
...n in a gene linked to dopamine regulation, can lea...aving for alcohol.// The protein alpha synuclein...of dopamine function. SNCA mutations can lead to s...generative disorder Parkinson's disease, which is ...
Other Medicine News:Health News:Aspirin Resistance Is Higher in Diabetics 2Health News:MRI Screening of Other Breast Crucial for Patients Diagnosed With Cancer in One Breast 2Health News:Choking Game, Rage Among US Teens, Evokes Deep Concern 2Health News:Not Parkinson’s Disease Alon 2
(Date:8/20/2008)... you currently have a study,that is falling behind...itment tools and a budget for media but still have...ed is an extra set of hands to help,your sites nav...ditional,administrative assistance and consultatio...ays Ms. Ann Kottcamp,President of Argonauta Commu...
(Date:8/19/2008)...ire-FirstCall/ --,Pharmaceutical company Pharmaxis... Phase 3 clinical trial evaluating the long term s...s has concluded with no serious,adverse events att...nt., A total of 123 subjects started treatment wi... completed the full 12 months of the trial. Of the...
(Date:8/19/2008)...rticle Sciences Inc. has,expanded its Combination ...lot production capabilities with the installation ...line. The core of the pilot line,comprising a Haa...injection,molder, enables the production of high-q...n gives Particle Sciences the ability to go from b...
(Date:8/19/2008)... to identify molecular,signature of motor neuron d...ewswire/ -- ALS Therapy,Development Institute (ALS...iomarker effort using blood samples collected thro...These ongoing projects are part of the,Institute,s...ion of genes,and proteins, at the onset of, and th...
Breaking Medicine Technology:Argonauta Assist(TM)ance: Argonauta Communications Strives to Enhance Site-Based Recruitment Efforts 212 Month Phase 3 Trial Finds Bronchitol Safe in Bronchiectasis 212 Month Phase 3 Trial Finds Bronchitol Safe in Bronchiectasis 3Particle Sciences Expands Its Combination Product Capabilities 2ALS Therapy Development Institute Partners with Clinical Centers to Establish Pathological Mechanisms of Lou Gehrig's Disease 2ALS Therapy Development Institute Partners with Clinical Centers to Establish Pathological Mechanisms of Lou Gehrig's Disease 3Sign Up Now for Project Management Essentials Three Days of Training in IT Project Management Fundamentals 2451 1Sign Up Now for Project Management Essentials Three Days of Training in IT Project Management Fundamentals 2451 2Commercial Insurers Reimbursement Rate to New Yorks Community Health Centers Jeopardizes Care 2448 1Commercial Insurers Reimbursement Rate to New Yorks Community Health Centers Jeopardizes Care 2448 2Commercial Insurers Reimbursement Rate to New Yorks Community Health Centers Jeopardizes Care 2448 3Commercial Insurers Reimbursement Rate to New Yorks Community Health Centers Jeopardizes Care 2448 4Kendle Appoints Ken Hintze PhD Vice President Global Clinical Safety 26 Pharmacovigilance 2445 1Kendle Appoints Ken Hintze PhD Vice President Global Clinical Safety 26 Pharmacovigilance 2445 2Kendle Appoints Ken Hintze PhD Vice President Global Clinical Safety 26 Pharmacovigilance 2445 3Kendle Appoints Ken Hintze PhD Vice President Global Clinical Safety 26 Pharmacovigilance 2445 4GenVault and the National Center for Forensic Science to Present Novel Technology for Room Temperature Storage of RNA 950 1GenVault and the National Center for Forensic Science to Present Novel Technology for Room Temperature Storage of RNA 950 2
....--(BUSINESS WIRE)--Jul 6, 2007 - BusinessWeek tod...rmaceutical and,biotechnology companies to be firs...atment for cardiovascular disease. While,angiogene... Boston,Scientific, Baxter, and Genzyme, among oth...iological therapy for advanced,coronary artery dis...
...in The Lancet on TMC125, an Investigational NNRTI,...ire/ -- Data from two,ongoing Phase 3 studies (DUE...ult patients with documented non-nucleoside revers...ibitor (PI),resistance reached an undetectable vir...le level < 50 HIV-1 RNA copies/mL) with,TMC125 (et...
Other Medicine Technology:BusinessWeek Article Highlights Promising Breakthrough Treatment,for Advanced Coronary Artery Disease 2TMC125 Showed Significant Virologic Response at Week 24 in,Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3,Trials 2TMC125 Showed Significant Virologic Response at Week 24 in,Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3,Trials 3TMC125 Showed Significant Virologic Response at Week 24 in,Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3,Trials 4
Singe-pull lace design provides easy-on application to provide support and immobilization of the wrist while preserving finger mobility
ManuTrain is an active wrist support that has optional features for increased stabilization.
Bird and Cronin, Inc. is a leading manufacturer of Patient Footwear, Orthopedic Softgoods, and Specialty Patient Care Products. Our products are of the highest quality and available in the USA and In
3-Point® Polycentric Hinged Ulnar Deviation Splint uses safe, mild to moderate force to align the hand with ulnar deviation at the MP joints. Dorsal-based splint does not impede grasp or pinch. R
Medicine Products: